As powerful new obesity drugs enter the U.S. market, medical associations are keen to advise their members on how to best use them for patients. That is where the debate begins. Some specialists advocate for broad use of drugs like Novo Nordisk’s Wegovy, alongside a healthy diet and exercise. Others recommend prioritizing them for high-risk patients, who have other conditions that are exacerbated by excess weight.
About the Author
